Related Experiment Videos
Abstract:
Mushrooms of the genus Psilocybe frequently are ingested by recreational drug users for their hallucinogenic effects. We present the case of a 30-year-old man who allegedly received an intravenous injection of an extract of Psilocybe mushrooms. His clinical course was characterized in part by vomiting, severe myalgias, hyperpyrexia, hypoxemia, and mild methemoglobinemia, and it was similar to two previously reported cases. The patient improved rapidly with supportive care.
Insights
Recreational intravenous injection of Psilocybe mushroom extract caused severe symptoms including fever and low oxygen. Prompt supportive care led to rapid patient recovery, highlighting potential risks of novel administration routes.
Area of Science:
- Toxicology
- Mycology
- Pharmacology
Background:
- Psilocybe mushrooms are known for their hallucinogenic properties and are often used recreationally.
- Intravenous administration of psychoactive substances carries unique risks compared to ingestion.
Observation:
- A 30-year-old man presented after allegedly receiving an intravenous injection of Psilocybe mushroom extract.
- Clinical manifestations included vomiting, severe muscle pain (myalgias), high fever (hyperpyrexia), low blood oxygen (hypoxemia), and mild methemoglobinemia.
Findings:
- The patient's symptoms were consistent with two previously reported cases of Psilocybe mushroom toxicity.
- The observed clinical course suggests a potential toxicological syndrome associated with intravenous Psilocybe extract administration.
Implications:
- This case underscores the potential dangers of non-traditional routes of administration for psychoactive substances.
- Further research into the specific toxic effects and safe administration of Psilocybe mushroom extracts is warranted.
- Healthcare providers should be aware of these potential adverse effects when evaluating patients with suspected recreational drug exposure.